Patents by Inventor Thomas Kirrane

Thomas Kirrane has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof
    Publication number: 20060014787
    Abstract: A compound of Formula (IA) or Formula (IB) wherein R1, R2, R3, R4, R5, R6, R7 and R8 are as defined herein, or a tautomer, prodrug, solvate, or salt thereof; pharmaceutical compositions containing such compounds, and methods of modulating the glucocorticoid receptor function and methods of treating disease-states or conditions mediated by the glucocorticoid receptor function or characterized by inflammatory, allergic, or proliferative processes in a patient using these compounds.
    Type: Application
    Filed: September 9, 2005
    Publication date: January 19, 2006
    Applicant: Boehringer Ingelheim Pharmaceuticals, Inc.
    Inventors: Thomas Kirrane, Daniel Kuzmich, John Proudfoot, Hossein Razavi, David Thomson
  • Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof
    Publication number: 20050282881
    Abstract: Compounds of Formula (IA) wherein R1, R2, R3, R4 and R5 are as defined herein for Formula (IA), or a tautomer, prodrug, solvate, or salt thereof; pharmaceutical compositions containing such compounds, and methods of modulating the glucocorticoid receptor function and methods of treating disease-states or conditions mediated by the glucocorticoid receptor function or characterized by inflammatory, allergic, or proliferative processes in a patient using these compounds.
    Type: Application
    Filed: July 20, 2005
    Publication date: December 22, 2005
    Applicant: Boehringer Ingelheim Pharmaceuticals, Inc.
    Inventors: Younes Bekkali, Rajashehar Betageri, Mario Cardozo, Thomas Gilmore, Thomas Kirrane, Daniel Kuzmich, John Proudfoot, Hidenori Takahashi, David Thomson, Renee Zindell
  • Glucocorticoid mimetics, methods of making them, pharmaceutical compositions and uses thereof
    Publication number: 20050234091
    Abstract: Compounds of Formula (I) wherein R1, R2, R3, R4, R5, R6 and X are as defined herein for Formula (IA) and Formula (IB), or a tautomer, prodrug, solvate, or salt thereof; pharmaceutical compositions containing such compounds, and methods of modulating the glucocorticoid receptor function and methods of treating disease-states or conditions mediated by the glucocorticoid receptor function or characterized by inflammatory, allergic, or proliferative processes in a patient using these compounds.
    Type: Application
    Filed: March 4, 2005
    Publication date: October 20, 2005
    Applicant: Boehringer Ingelheim Pharmaceuticals, Inc.
    Inventors: John Regan, Thomas Lee, David Thomson, Thomas Kirrane, Daniel Kuzmich, John Proudfoot, Younes Bekkali, Renee Zindell
  • Glucocorticoid mimetics, methods of making them, pharmaceutical compositions and uses thereof
    Publication number: 20050203128
    Abstract: Compounds of Formula (IA) and Formula (IB) where in R1 stands for the following group (the dashed line indicates the point of attachment) and R2, R3, R4, R5, R6, Y, Z, X1 and X2 are as defined herein for Formula (IA) and Formula (IB), or a tautomer, prodrug, solvate, or salt thereof; pharmaceutical compositions containing such compounds, and methods of modulating the glucocorticoid receptor function and methods of treating disease-states or conditions mediated by the glucocorticoid receptor function or characterized by inflammatory, allergic, or proliferative processes in a patient using these compounds.
    Type: Application
    Filed: March 4, 2005
    Publication date: September 15, 2005
    Applicant: Boehringer Ingelheim Pharmaceuticals, Inc.
    Inventors: Thomas Kirrane, Daniel Kuzmich, John Proudfoot
  • Glucocorticoid mimetics, methods of making them, pharmaceutical compositions and uses thereof
    Publication number: 20050176706
    Abstract: Compounds of Formula (IA), (IB), (IC), and (ID) wherein R1, R2, R3, R4, R5, and R6 are as respectively defined herein for Formula (IA), (IB), (IC), and (ID), or a tautomer, prodrug, solvate, or salt thereof; pharmaceutical compositions containing such compounds, and methods of modulating the glucocorticoid receptor function and methods of treating disease-states or conditions mediated by the glucocorticoid receptor function or characterized by inflammatory, allergic, or proliferative processes in a patient using these compounds.
    Type: Application
    Filed: September 22, 2004
    Publication date: August 11, 2005
    Applicant: Boehringer Ingelheim Pharmaceuticals, Inc.
    Inventors: Younes Bekkali, Rajashekhar Betageri, Michel Emmanuel, Abdelhakim Hammach, Christian Joachim Harcken, Thomas Kirrane, Daniel Kuzmich, Thomas Lee, Pingrong Liu, Usha Patel, John Proudfoot, Hossein Razavi, Doris Riether, Hidenori Takahashi, David Thomson, Ji Wang, Renee Zindell